| Elene Evyenia Lindberg, MS, OTR/L | |
|
5710 Baker Rd, Minnetonka, MN 55345-5901 | |
| (952) 767-4200 | |
| (952) 767-4211 |
| Full Name | Elene Evyenia Lindberg |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5710 Baker Rd, Minnetonka, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063897544 | NPI | - | NPPES |
| 115000 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 104914 (Minnesota) | Primary |
| Provider Name | Autism Opportunities Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447348172 PECOS PAC ID: 1153649009 Enrollment ID: O20150406001591 |
News Archive
A team led by Krzysztof Palczewski, Ph.D., chair of pharmacology at the Case Western Reserve University School of Medicine, has taken the first steps in treating an eye disease causing irreversible congenital blindness in millions of people worldwide by successfully testing two new treatments in mice.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that the United States Patent Office has granted U.S. patent no. 9,107,823 ('823 Patent) covering novel topical foam formulations that include dimethyl sulfoxide (DMSO) together with certain drug actives.
Diabetes is prevalent among adults aged 65 and older and can lead to a number of other serious health issues. Maintaining control of blood glucose levels is one of the most important actions diabetics can take to control their illness. New technology is designed to make self-monitoring easier and more accessible than ever before, but often tech products fail to accommodate some older users.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the revamping of Mosby's Index, the most robust journal abstracts and indexing database available for nurses and other healthcare professionals.
GTx, Inc. announced that the company has been awarded approximately $1.2 million by the United States Government under the Qualifying Therapeutic Discovery Project Program (QTDP), a $1 billion fund established under HR: 3590 Patient Protection and Affordable Care Act.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elene Evyenia Lindberg, MS, OTR/L 5710 Baker Rd., Minnetonka, MN 55345 Ph: (952) 767-4200 | Elene Evyenia Lindberg, MS, OTR/L 5710 Baker Rd, Minnetonka, MN 55345-5901 Ph: (952) 767-4200 |
News Archive
A team led by Krzysztof Palczewski, Ph.D., chair of pharmacology at the Case Western Reserve University School of Medicine, has taken the first steps in treating an eye disease causing irreversible congenital blindness in millions of people worldwide by successfully testing two new treatments in mice.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that the United States Patent Office has granted U.S. patent no. 9,107,823 ('823 Patent) covering novel topical foam formulations that include dimethyl sulfoxide (DMSO) together with certain drug actives.
Diabetes is prevalent among adults aged 65 and older and can lead to a number of other serious health issues. Maintaining control of blood glucose levels is one of the most important actions diabetics can take to control their illness. New technology is designed to make self-monitoring easier and more accessible than ever before, but often tech products fail to accommodate some older users.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the revamping of Mosby's Index, the most robust journal abstracts and indexing database available for nurses and other healthcare professionals.
GTx, Inc. announced that the company has been awarded approximately $1.2 million by the United States Government under the Qualifying Therapeutic Discovery Project Program (QTDP), a $1 billion fund established under HR: 3590 Patient Protection and Affordable Care Act.
› Verified 7 days ago
Mallory Hoffman, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5710 Baker Rd, Minnetonka, MN 55345 Phone: 952-767-4200 Fax: 952-767-4211 | |
Emily Hoyer, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 500 Carlson Pkwy, Minnetonka, MN 55305 Phone: 877-407-3422 | |
Kara Juker, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 500 Carlson Pkwy, Minnetonka, MN 55305 Phone: 877-407-3422 Fax: 877-407-4329 | |
Jessica Lynn Stewart, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 5501 Feltl Rd, Minnetonka, MN 55343 Phone: 952-746-0222 | |
Sydney Mckenzie, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 10653 Wayzata Blvd Ste 200, Minnetonka, MN 55305 Phone: 612-364-1901 | |
Lani Hanson, Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 10653 Wayzata Blvd Ste 200, Minnetonka, MN 55305 Phone: 952-224-1919 |